CSIMarket
 


Revolution Medicines Inc   (RVMD)
Other Ticker:  
 
 

RVMD's Revenue Growth by Quarter and Year

Revolution Medicines Inc 's Revenue results by quarter and year




RVMD Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 15.33 9.46 8.75
III Quarter September 0.00 3.36 1.10 12.66
II Quarter June 3.82 9.12 8.70 10.03
I Quarter March 7.01 7.58 10.13 11.55
FY   10.83 35.39 29.39 42.99



RVMD Revenue third quarter 2023 Y/Y Growth Comment
Revolution Medicines Inc in the third quarter 2023 recorded of $ 0.00 millions.

Looking into third quarter 2023 results within Biotechnology & Pharmaceuticals industry 9 other companies have achieved higher Revenue growth. While Revolution Medicines Inc ' s Revenue no change of % ranks overall at the positon no. 638 in the third quarter 2023.




RVMD Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - 62.05 % 8.11 % -
III Quarter September - 205.45 % -91.31 % -
II Quarter June -58.11 % 4.83 % -13.26 % -
I Quarter March -7.52 % -25.17 % -12.29 % -
FY   - 20.42 % -31.64 % -

Financial Statements
Revolution Medicines Inc 's third quarter 2023 Revenue $ 0.00 millions RVMD's Income Statement
Revolution Medicines Inc 's third quarter 2022 Revenue $ 3.36 millions Quarterly RVMD's Income Statement
New: More RVMD's historic Revenue Growth >>


RVMD Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 356.25 % 760 % -30.88 %
III Quarter September - -63.16 % -87.36 % 26.22 %
II Quarter June -45.51 % 20.32 % -14.12 % -13.16 %
I Quarter March -54.27 % -19.87 % 15.77 % -
FY (Year on Year)   - 20.42 % -31.64 % -




Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #10
Healthcare Sector #95
Overall #638

Revenue Y/Y Growth Statistics
High Average Low
29.73 % -5.43 % -35.44 %
(Mar 31 2023)   (Mar 31 2022)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #10
Healthcare Sector #95
Overall #638
Revenue Y/Y Growth Statistics
High Average Low
29.73 % -5.43 % -35.44 %
(Mar 31 2023)   (Mar 31 2022)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Revolution Medicines Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RVMD's III. Quarter Q/Q Revenue Comment
Current results of 0.00 millions by Revolution Medicines Inc come out even less good compare to the 3.82 millions in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Revolution Medicines Inc achieved highest sequential Revenue growth. While Revolution Medicines Inc 's Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RVMD's III. Quarter Q/Q Revenue Comment
Recent results of 0.00 millions by Revolution Medicines Inc look even worse compare to the 3.82 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Revolution Medicines Inc achieved highest sequential Revenue growth. While Revolution Medicines Inc 's Revenue growth quarter on quarter, overall rank is .


Revolution Medicines Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 0.00 $ 29.52 $ 34.82 $ 35.38 $ 29.51
Y / Y Revenue Growth (TTM) - 8.33 % 29.73 % 20.38 % 2.89 %
Year on Year Revenue Growth Overall Ranking # 896 # 2101 # 2675 # 2286 # 3327
Seqeuential Revenue Change (TTM) - -15.2 % -1.59 % 19.89 % 8.27 %
Seq. Revenue Growth (TTM) Overall Ranking # 1488 # 1477 # 2380 # 1712 # 377




Cumulative Revenue growth Comment
Revolution Medicines Inc realized trailing twelve months of $ 0 millions, in the Sep 30 2023, compare to Revenue of $ 30 millions a year ago.

In the Healthcare sector 112 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 896, from total ranking in previous quarter at 2101.

Revenue TTM Q/Q Growth Statistics
High Average Low
29.73 %
-5.43 %
-35.44 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 28
Healthcare Sector # 113
Overall # 896

Revenue TTM Y/Y Growth Statistics
High Average Low
29.73 %
-5.43 %
-35.44 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 281
S&P 500 # 1488
Cumulative Revenue growth Comment
Revolution Medicines Inc realized trailing twelve months of $ 0 millions, in the Sep 30 2023, compare to Revenue of $ 30 millions a year ago.

In the Healthcare sector 112 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 896, from total ranking in previous quarter at 2101.

Revenue TTM Q/Q Growth Statistics
High Average Low
29.73 %
-5.43 %
-35.44 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 28
Healthcare Sector # 113
Overall # 896

Revenue TTM Y/Y Growth Statistics
High Average Low
29.73 %
-5.43 %
-35.44 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 281
S&P 500 # 1488




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RVMD's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for RVMD's Competitors
Revenue Growth for Revolution Medicines Inc 's Suppliers
Revenue Growth for RVMD's Customers

You may also want to know
RVMD's Annual Growth Rates RVMD's Profitability Ratios RVMD's Asset Turnover Ratio RVMD's Dividend Growth
RVMD's Roe RVMD's Valuation Ratios RVMD's Financial Strength Ratios RVMD's Dividend Payout Ratio
RVMD's Roa RVMD's Inventory Turnover Ratio RVMD's Growth Rates RVMD's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Procyon Corporation-0.22%$ -0.221 millions
Amedisys Inc -0.31%$ -0.314 millions
Karyopharm Therapeutics Inc -0.38%$ -0.376 millions
Establishment Labs Holdings Inc -0.50%$ -0.505 millions
Opko Health Inc -0.64%$ -0.639 millions
Integra Lifesciences Holdings Corp-0.72%$ -0.719 millions
Healthcare Services Group Inc -0.75%$ -0.748 millions
Phibro Animal Health Corporation-0.77%$ -0.772 millions
Bellicum Pharmaceuticals Inc -0.89%$ -0.890 millions
Prestige Consumer Healthcare Inc -1.12%$ -1.125 millions
Sharecare Inc -1.13%$ -1.127 millions
Lifevantage Corp-1.14%$ -1.140 millions
Organon and Co -1.17%$ -1.171 millions
Optinose Inc -1.27%$ -1.270 millions
Baxter International Inc -1.72%$ -1.723 millions
Puma Biotechnology Inc -1.73%$ -1.727 millions
Blueprint Medicines Corporation-1.76%$ -1.763 millions
Standard Biotools Inc -1.92%$ -1.918 millions
Pacira Biosciences inc -2.11%$ -2.114 millions
Bristol myers Squibb Company-2.25%$ -2.246 millions
Aurinia Pharmaceuticals Inc -2.27%$ -2.266 millions
Abbott Laboratories-2.56%$ -2.565 millions
Enhabit Inc -2.79%$ -2.785 millions
Novocure Limited-2.81%$ -2.807 millions
Uniqure N v -2.90%$ -2.899 millions
Vaso Corporation-2.92%$ -2.925 millions
Scientific Industries Inc -3.16%$ -3.165 millions
Akumin Inc -3.21%$ -3.205 millions
Syros Pharmaceuticals Inc -3.32%$ -3.315 millions
Viatris Inc -3.34%$ -3.342 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com